CLONING OF PLASMODIUM FALCIPARUM ERITHROCYTE BINDING ANTIGEN 175 (PFEBA-175) RIII-V GENE FROM TIMIKA ISOLATE FOR MALARIA VACCINES DEVELOPMENT

175 kDa Plasmodium falciparum erythrocyte binding antigen (PfEBA-175) is a protein that plays an important role in human erithrocyte cell invasion by a parasite, Plasmodium falciparum, which cause malaria disease. This protein is a potential malaria vaccine candidate as it can induces...

Full description

Saved in:
Bibliographic Details
Main Author: Aditya Nugraha, Dadi
Format: Final Project
Language:Indonesia
Subjects:
Online Access:https://digilib.itb.ac.id/gdl/view/35736
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Institut Teknologi Bandung
Language: Indonesia
id id-itb.:35736
spelling id-itb.:357362019-03-01T08:13:15ZCLONING OF PLASMODIUM FALCIPARUM ERITHROCYTE BINDING ANTIGEN 175 (PFEBA-175) RIII-V GENE FROM TIMIKA ISOLATE FOR MALARIA VACCINES DEVELOPMENT Aditya Nugraha, Dadi Kimia Indonesia Final Project PfEBA-175-RIII-V, malaria, cloning, ef3-5, polymerase chain reaction INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/35736 175 kDa Plasmodium falciparum erythrocyte binding antigen (PfEBA-175) is a protein that plays an important role in human erithrocyte cell invasion by a parasite, Plasmodium falciparum, which cause malaria disease. This protein is a potential malaria vaccine candidate as it can induces antibody production in human body which inhibit malaria parasite invasion. PfEBA-175 has been known to binding glycoporin A (GpA), a receptor protein in erithrocyte cell membrane surface during invasion. PfEBA-175 shares similar form with type I transmembrane protein and it’s extracelular has 6 regions. Antibodies for RIII-V has been shown can inhibit malaria parasite growth and protect patient from clinical malaria symptoms. In this study, gene that encodes PfEBA-175 RIII-V (ef3-5) has been cloned by standard methods. The gene was amplified by PCR using spesific primers (Ta=63oC, increment -2 oC /cycle) and genomic DNA of local isolate P. falciparum was used as a template. The amplicons were inserted to cloning vector, pGEM-t Easy through ligation to get recombinant plasmids, pGEMef3-5. The recombinant plasmid was transformed into E. coli TOP10 F’ for maintaining. The pGEMef3-5 was extracted from transformant E. coli and after that, the plasmid were evaluated by restriction digestion analysis using enzymes and were confirmed by DNA. DNA alignment of pGEMef3-5 and ef3-5 (3D7) shows that the cloning was performed correctly with similarity, 99.63% (clone 4) and 99.50% (clone 10). DNA sequencing analysis shows clone 4 have base mutation at base position, 23(G?A), 542 (T?C), 939 and 1313 (A?G) and 1019 (G?A). Clone 10 have base mutation at base position, 23 (G?A), 542 (T?C), 939 and 1313 (A?G) and deletion at 458 and 460. The Results indicate this mutations might be genetic variation resulted from isolate text
institution Institut Teknologi Bandung
building Institut Teknologi Bandung Library
continent Asia
country Indonesia
Indonesia
content_provider Institut Teknologi Bandung
collection Digital ITB
language Indonesia
topic Kimia
spellingShingle Kimia
Aditya Nugraha, Dadi
CLONING OF PLASMODIUM FALCIPARUM ERITHROCYTE BINDING ANTIGEN 175 (PFEBA-175) RIII-V GENE FROM TIMIKA ISOLATE FOR MALARIA VACCINES DEVELOPMENT
description 175 kDa Plasmodium falciparum erythrocyte binding antigen (PfEBA-175) is a protein that plays an important role in human erithrocyte cell invasion by a parasite, Plasmodium falciparum, which cause malaria disease. This protein is a potential malaria vaccine candidate as it can induces antibody production in human body which inhibit malaria parasite invasion. PfEBA-175 has been known to binding glycoporin A (GpA), a receptor protein in erithrocyte cell membrane surface during invasion. PfEBA-175 shares similar form with type I transmembrane protein and it’s extracelular has 6 regions. Antibodies for RIII-V has been shown can inhibit malaria parasite growth and protect patient from clinical malaria symptoms. In this study, gene that encodes PfEBA-175 RIII-V (ef3-5) has been cloned by standard methods. The gene was amplified by PCR using spesific primers (Ta=63oC, increment -2 oC /cycle) and genomic DNA of local isolate P. falciparum was used as a template. The amplicons were inserted to cloning vector, pGEM-t Easy through ligation to get recombinant plasmids, pGEMef3-5. The recombinant plasmid was transformed into E. coli TOP10 F’ for maintaining. The pGEMef3-5 was extracted from transformant E. coli and after that, the plasmid were evaluated by restriction digestion analysis using enzymes and were confirmed by DNA. DNA alignment of pGEMef3-5 and ef3-5 (3D7) shows that the cloning was performed correctly with similarity, 99.63% (clone 4) and 99.50% (clone 10). DNA sequencing analysis shows clone 4 have base mutation at base position, 23(G?A), 542 (T?C), 939 and 1313 (A?G) and 1019 (G?A). Clone 10 have base mutation at base position, 23 (G?A), 542 (T?C), 939 and 1313 (A?G) and deletion at 458 and 460. The Results indicate this mutations might be genetic variation resulted from isolate
format Final Project
author Aditya Nugraha, Dadi
author_facet Aditya Nugraha, Dadi
author_sort Aditya Nugraha, Dadi
title CLONING OF PLASMODIUM FALCIPARUM ERITHROCYTE BINDING ANTIGEN 175 (PFEBA-175) RIII-V GENE FROM TIMIKA ISOLATE FOR MALARIA VACCINES DEVELOPMENT
title_short CLONING OF PLASMODIUM FALCIPARUM ERITHROCYTE BINDING ANTIGEN 175 (PFEBA-175) RIII-V GENE FROM TIMIKA ISOLATE FOR MALARIA VACCINES DEVELOPMENT
title_full CLONING OF PLASMODIUM FALCIPARUM ERITHROCYTE BINDING ANTIGEN 175 (PFEBA-175) RIII-V GENE FROM TIMIKA ISOLATE FOR MALARIA VACCINES DEVELOPMENT
title_fullStr CLONING OF PLASMODIUM FALCIPARUM ERITHROCYTE BINDING ANTIGEN 175 (PFEBA-175) RIII-V GENE FROM TIMIKA ISOLATE FOR MALARIA VACCINES DEVELOPMENT
title_full_unstemmed CLONING OF PLASMODIUM FALCIPARUM ERITHROCYTE BINDING ANTIGEN 175 (PFEBA-175) RIII-V GENE FROM TIMIKA ISOLATE FOR MALARIA VACCINES DEVELOPMENT
title_sort cloning of plasmodium falciparum erithrocyte binding antigen 175 (pfeba-175) riii-v gene from timika isolate for malaria vaccines development
url https://digilib.itb.ac.id/gdl/view/35736
_version_ 1822268565976252416